About Sharis, Christine M MD (UIA Investigator)
Clinical Trials at Sharis, Christine M MD (UIA Investigator)
During the past decade, Sharis, Christine M MD (UIA Investigator) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sharis, Christine M MD (UIA Investigator)"
#1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Sharis, Christine M MD (UIA Investigator)
According to Clinical.Site data, the most researched conditions in "Sharis, Christine M MD (UIA Investigator)" are
"Adult Giant Cell Glioblastoma" (3 trials), "Adult Glioblastoma" (3 trials), "Adult Gliosarcoma" (3 trials), "Adenocarcinoma of the Prostate" (2 trials) and "Breast Adenocarcinoma" (2 trials). Many other conditions were trialed in "Sharis, Christine M MD (UIA Investigator)" in a lesser frequency.
Clinical Trials Intervention Types at Sharis, Christine M MD (UIA Investigator)
Most popular intervention types in "Sharis, Christine M MD (UIA Investigator)" are "Drug" (27 trials), "Other" (15 trials), "Biological" (14 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Bevacizumab" (9 trials), "Quality-of-Life Assessment" (6 trials), "Paclitaxel" (4 trials) and "Placebo" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Sharis, Christine M MD (UIA Investigator)
The vast majority of trials in "Sharis, Christine M MD (UIA Investigator)" are
22 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Sharis, Christine M MD (UIA Investigator)
Currently, there are NaN active trials in "Sharis, Christine M MD (UIA Investigator)".
undefined are not yet recruiting,
undefined are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Sharis, Christine M MD (UIA Investigator),
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Sharis, Christine M MD (UIA Investigator), 2 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".